Atenolol use is associated with long-term mortality in community-dwelling older adults with hypertension

Gianluca Testa, Francesco Cacciatore, David Della-Morte, Francesca Mazzella, Chiara Mastrobuoni, Gianluigi Galizia, Gaetano Gargiulo, Franco Rengo, Domenico Bonaduce, Pasquale Abete

Research output: Contribution to journalArticlepeer-review

Abstract

Aim: The role of atenolol, a non-vasodilating beta-blocker drug, on long-term mortality in hypertensive older adults is still unclear. The aim of the present study was to evaluate long-term mortality in community-dwelling hypertensive older adults taking atenolol. Methods: Long-term mortality after 12-year follow up in isolated hypertensive older adults (n=972) was analyzed. The patients were stratified in the presence and absence of atenolol use. Systolic, diastolic and pulse arterial pressure were measured. Results: Older adults taking atenolol showed a greater mortality and higher pulse arterial pressure values than those not taking atenolol (73.9% vs 55.0%; P=0.047 and 74.7±14.1 vs 63.0±14.2mmHg, P

Original languageEnglish
Pages (from-to)153-158
Number of pages6
JournalGeriatrics and Gerontology International
Volume14
Issue number1
DOIs
Publication statusPublished - Jan 2014

Keywords

  • Atenolol
  • Elderly
  • Hypertension
  • Long-term mortality
  • Pulse arterial pressure

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Gerontology
  • Health(social science)

Fingerprint Dive into the research topics of 'Atenolol use is associated with long-term mortality in community-dwelling older adults with hypertension'. Together they form a unique fingerprint.

Cite this